Baker Phillip, Smith Julie, Salmon Libby, Friel Sharon, Kent George, Iellamo Alessandro, Dadhich J P, Renfrew Mary J
1Health Equity and Governance Group,RegNet School of Regulation and Global Governance,H.C. Coombs Extension Building #8,Fellows Road,Australian National University,Canberra,ACT 0200,Australia.
2Department of Political Science,University of Hawai'i, Honolulu,HI,USA.
Public Health Nutr. 2016 Oct;19(14):2540-50. doi: 10.1017/S1368980016001117. Epub 2016 May 23.
The marketing of infant/child milk-based formulas (MF) contributes to suboptimal breast-feeding and adversely affects child and maternal health outcomes globally. However, little is known about recent changes in MF markets. The present study describes contemporary trends and patterns of MF sales at the global, regional and country levels.
Descriptive statistics of trends and patterns in MF sales volume per infant/child for the years 2008-2013 and projections to 2018, using industry-sourced data.
Eighty countries categorized by country income bracket, for developing countries by region, and in countries with the largest infant/child populations.
MF categories included total (for ages 0-36 months), infant (0-6 months), follow-up (7-12 months), toddler (13-36 months) and special (0-6 months).
In 2008-2013 world total MF sales grew by 40·8 % from 5·5 to 7·8 kg per infant/child/year, a figure predicted to increase to 10·8 kg by 2018. Growth was most rapid in East Asia particularly in China, Indonesia, Thailand and Vietnam and was led by the infant and follow-up formula categories. Sales volume per infant/child was positively associated with country income level although with wide variability between countries.
A global infant and young child feeding (IYCF) transition towards diets higher in MF is underway and is expected to continue apace. The observed increase in MF sales raises serious concern for global child and maternal health, particularly in East Asia, and calls into question the efficacy of current regulatory regimes designed to protect and promote optimal IYCF. The observed changes have not been captured by existing IYCF monitoring systems.
婴幼儿配方奶粉的市场营销导致母乳喂养率未达最佳水平,并对全球儿童和孕产妇健康结果产生不利影响。然而,人们对配方奶粉市场的近期变化知之甚少。本研究描述了全球、区域和国家层面配方奶粉销售的当代趋势和模式。
利用行业来源的数据,对2008 - 2013年期间每名婴幼儿的配方奶粉销售量趋势和模式进行描述性统计,并预测到2018年的情况。
按国家收入等级分类的80个国家,按地区分类的发展中国家,以及婴幼儿人口最多的国家。
配方奶粉类别包括总计(适用于0 - 36个月龄)、婴儿(0 - 6个月)、后续(7 - 12个月)、幼儿(13 - 36个月)和特殊(0 - 6个月)。
2008 - 2013年,全球配方奶粉总销售额增长了40.8%,从每名婴幼儿每年5.5千克增至7.8千克,预计到2018年将增至10.8千克。东亚地区增长最为迅速,尤其是中国、印度尼西亚、泰国和越南,增长主要由婴儿配方奶粉和后续配方奶粉类别带动。每名婴幼儿的销售量与国家收入水平呈正相关,尽管各国之间存在很大差异。
全球婴幼儿喂养(IYCF)正朝着食用更多配方奶粉的饮食模式转变,预计这一趋势将继续快速发展。观察到的配方奶粉销售额增长引发了对全球儿童和孕产妇健康的严重关切,尤其是在东亚地区,并对旨在保护和促进最佳IYCF的现行监管制度的有效性提出了质疑。现有的IYCF监测系统未捕捉到观察到的这些变化。